FDA Approves Label Change for Alzheimer’s Amyloid Drug

(MedPage Today) — The FDA approved a label update with a new titration schedule for donanemab (Kisunla), an anti-amyloid drug approved to treat early symptomatic Alzheimer’s disease, drugmaker Eli Lilly said.
The move was designed to reduce the…